No Data
No Data
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading
Health care stocks were edging up Friday afternoon, with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) up less than 0.1%. The iShares Biotechnology ETF (IBB)
Sector Update: Health Care
Health care stocks were edging up Friday afternoon, with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) up less than 0.1%. The iShares Biotechnology ETF (IBB)
CG Oncology Bladder Cancer Treatment to Achieve $4 Billion in Sales by 2037, BofA Says
CG Oncology's (CGON) cretostimogene immunotherapy to treat bladder cancer is expected to achieve over $4 billion in non-risk adjusted sales by 2037, BofA Securities said in a note Friday. Cretostimoge
A Closer Look at 9 Analyst Recommendations For CG Oncology
9 analysts have expressed a variety of opinions on CG Oncology (NASDAQ:CGON) over the past quarter, offering a diverse set of opinions from bullish to bearish.The following table encapsulates their re
Express News | CG Oncology Inc : BofA Global Research Initiates Coverage With Buy Rating; Price Objective $65
CG Oncology Initiated at Buy by B of A Securities
CG Oncology Initiated at Buy by B of A Securities
No Data
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.